Sign Up to like & get
recommendations!
0
Published in 2025 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.70085
Abstract: To assess whether exposure to an extended‐release (ER) oxycodone with abuse deterrent properties (ADF) reduced tampering of oxycodone in a real‐world, postmarket setting to address the thinking behind Category 4 labeling by the FDA.
read more here.
Keywords:
oxycodone;
deterrent properties;
abuse deterrent;
extended release ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinics in Orthopedic Surgery"
DOI: 10.4055/cios.2018.10.1.33
Abstract: Background A prolonged-release formulation of oxycodone/naloxone has been shown to be effective in European populations for the management of chronic moderate to severe pain. However, no clinical data exist for its use in Korean patients.…
read more here.
Keywords:
prolonged release;
korean patients;
release oxycodone;
oxycodone naloxone ... See more keywords